Compound Detail
CHEMBL4635117
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4635117 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QGXCAHQDBNSMDO-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
7
Publications
0
Known Names
Molecular Properties
423.9
MW (Da)
4.46
ALogP
7
HBA
2
HBD
69.2
PSA (Ų)
0.61
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 5.04
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| CDK2/Cyclin A2 CHEMBL3038469 | IC50 | 5.04 | 5.04 | 9180.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| CDK2/Cyclin A2 | IC50 | = | 9180.0 | nM | 5.04 | Inhibition of recombinant human full-length N-terminal GST-tagged CDK2/cyclinA2 ... | 32129996 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32129996 | 10.1021/acs.jmedchem.9b02121 | CDK6/cyclin D3 | 1 |
| 32129996 | 10.1021/acs.jmedchem.9b02121 | CDK9/Cyclin K | 1 |
| 32129996 | 10.1021/acs.jmedchem.9b02121 | CDK2/Cyclin A2 | 1 |
| 32129996 | 10.1021/acs.jmedchem.9b02121 | MDA-MB-231 | 1 |
| 32129996 | 10.1021/acs.jmedchem.9b02121 | Jurkat | 1 |
| 32129996 | 10.1021/acs.jmedchem.9b02121 | MCF7 | 1 |
| 32129996 | 10.1021/acs.jmedchem.9b02121 | L02 | 1 |
Data from ChEMBL 36 via Core Engine